0001140361-17-033206.txt : 20170824 0001140361-17-033206.hdr.sgml : 20170824 20170824180215 ACCESSION NUMBER: 0001140361-17-033206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170822 FILED AS OF DATE: 20170824 DATE AS OF CHANGE: 20170824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowlinson Scott W CENTRAL INDEX KEY: 0001655979 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 171050126 MAIL ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY STREET 2: BARTON OAKS PLAZA ONE, SUITE 250 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250 STREET 2: BARTON OAKS PLAZA ONE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250 STREET 2: BARTON OAKS PLAZA ONE CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc1.xml FORM 4 X0306 4 2017-08-22 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001655979 Rowlinson Scott W 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746 0 1 0 0 VP, Research Employee Stock Option (right to buy) 3.10 2017-08-22 4 A 0 25000 0 A 2027-08-21 Common Stock 25000 25000 D The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Charles N. York II, by power of attorney 2017-08-24